3-substituted-1-H-indole pyrazole derivative compound as well as preparation method and application thereof

By developing three-position substituted-1-H-indopyrazole derivative compounds, the problem of poor inhibition of rice white leaf blight, citrus canker, kiwi fruit canker and tobacco green wilt in the prior art has been solved. , effectively inhibiting these pathogens and tumor cells, and providing new agricultural pest control and anti-tumor drug solutions.

CN119019387APending Publication Date: 2024-11-26GUIZHOU UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411061257.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-05
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

In the prior art, there is a lack of a drug that can effectively inhibit rice white leaf blight, citrus canker, kiwi fruit canker and tobacco green wilt bacteria, and also has a good inhibitory effect on tumor cells.

Method used

A class of 3-position substituted-1-H-indopyrazole derivative compounds were developed. Through a simplified synthesis step and easy-to-get raw materials, compounds that have inhibitory effects on a variety of plant pathogens and tumor cells were prepared and put into use. Applied in agricultural pests and anti-tumor drugs.

Benefits of technology

This compound showed significant inhibitory effect on target pathogens and tumor cells, providing an important scientific basis for agricultural pest control and anti-tumor drug research and development.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119019387A_ABST
    Figure CN119019387A_ABST
Patent Text Reader

Abstract

The invention discloses a chemical preparation method and application of a 3-substituted-1-H-indole pyrazole derivative, the compound has a structure as shown in the following general formula: # imgabs0 is based on a 3-pyrazole indole structure, and a series of compounds containing urea structure fragments, piperazine and different phenyl substitutions are synthesized. The compound has a good inhibition effect on pathogenic bacteria and tumor cells; the compound has a good inhibition effect on pathogenic bacteria such as Xanthomonas oryzae pv. Oryzae, Xanthomonas citri pv. Citri, Kiwi berry bacterial canker, ralstonia solanacearum, K562 (chronic myelogenous leukemia cells), A549 (human non-small cell lung cancer cells), PC-3 (human prostate cancer cells), 5637 (human bladder cancer cells) and the like, and an important scientific basis is provided for research, development and creation of new pesticides.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of pharmaceutical chemistry, and specifically relates to a class of 3-substituted-1-H-indole pyrazole derivative compounds and a preparation method and application thereof. Background Art

[0002] Among nitrogen-containing heterocyclic compounds, indole derivatives exhibit diverse biological activities. Indole is a natural product widely found in animals, plants and microorganisms. Natural products containing indole and synthetic indole derivatives have a variety of biological activities, such as anti-tumor, antibacterial, antiviral, anti-inflammatory and other pharmacological effects, and have good development potential in the fields of medicine and pesticides.

[0003] In 2016, Zhang et al. designed and synthesized a series of indole-pyrazole compounds and conducted biological evaluations on them as potential inhibitors of tubulin polymerization. The most active compounds had IC values ​​of 1.17 for four cell lines: human cervical cancer cell line (HeLa), breast cancer cell line (MCF-7), non-small cell lung cell line (A549), and hepatocellular carcinoma cell line (HepG2). 50 The values ​​were 0.21μM, 0.29μm, 0.26μM and 0.31μM respectively. Studies have found that it can effectively inhibit tubulin assembly, causing cells to accumulate in the G2 / M phase, and severely destroy the microtubule system, which can effectively induce apoptosis of HeLa cells.

[0004] In 2021, Katharigatta et al. used the aryl hydrocarbon receptor (AhR) as a drug target, optimized and synthesized 3-pyrazoloindole derivatives based on the results of molecular docking studies, and tested their in vitro cytotoxicity against four human cancer cell lines. Three of the compounds containing hydroxyphenyl substitutions showed significant cytotoxicity against non-small cell lung cancer (A549) (IC 50 The results of this study showed that the introduction of a pyrazole heterocycle at the 3-position of indole can enhance the selectivity and cytotoxicity of A549 and LnCaP cells. In addition, marketed anti-tumor drugs, such as melatonin, vinorelbine and sunitinib, all contain indole structures.

[0005] Indole derivatives also show good antibacterial activity and can be used as antibacterial agents. CAI et al. isolated a new dimeric monoterpene indole alkaloid polonidine A from Penicillium polonium TY12, which has moderate antibacterial activity against Staphylococcus aureus, with a minimum inhibitory mass concentration (MIC) value of 4.0 μg mL -1 .

[0006] In 2018, Tian et al. studied the antibacterial activity of previously synthesized 2-(N-phenylsulfonyl indol-3-yl)-3-N-acyl-5-phenyl-1,3,4-oxadiazole compounds. -1 At the same time, the mycelial growth rate method was used to determine their indoor antibacterial activities against wheat fusarium rust, cabbage black spot pathogen, cotton wilt pathogen, rice blast pathogen and tobacco brown spot pathogen. It was found that the synthesized compounds had good activity against the five plant pathogens, with broad spectrum and potential application value. Pyrazole is a five-membered N-aromatic heterocyclic compound with "biological characteristics" containing two nitrogen atoms in adjacent positions. Nowadays, pyrazole and its derivatives have attracted much attention due to their wide range of pharmaceutical activities. They have been proved to be important structural components of active pharmaceutical ingredients (API) and various pyrazole compounds. Molecules carrying pyrazole moieties show a wide range of pharmaceutical activities, such as anticancer, antitumor, insecticide, antiviral, antifungal, etc.

[0007] In 2019, O'Malley et al. designed and synthesized a series of pyrazolo[1,5-a]pyridine compounds as potential C-terminal tyrosine kinase inhibitors, which act as negative regulators of T cell activation by inhibiting the phosphorylation of LCK. The in vitro LCK kinase activity test proved that this series of pyrazolo[1,5-a]pyridine compounds have the effect of inhibiting C-terminal tyrosine kinase. One of the compounds has an IC50 value of 4nM for LCK.

[0008] In 2021, Sturbaut et al. reported the synthesis of a group of trisubstituted pyrazoles, one of which could disrupt the YAP / TAZ-TEAD interaction in HEK293T cells and inhibit TEAD target genes and cell proliferation in MDA-MB-231 cells.

[0009] Among the 24 SDHI fungicides that have been on the market, more than half of the drugs have pyrazole groups, such as fluopicolide, penthiopyrad, bixafen, fluopicolide, etc., which all have broad-spectrum and highly effective fungicidal activity and have made outstanding contributions to the development of fungicides.

[0010] In 2022, Tang et al. designed and synthesized a series of novel pyrazole furan / thiophene carboxamide derivatives in order to discover new fungicides against succinate dehydrogenase (SDH), and studied the antifungal activity of these compounds against Botrytis cinerea, rice blast, graminearum head blight, apple ring rot and green mold. The bioassay results showed that most compounds had significant inhibitory activity against several fungi at 20 μg / mL. Some of these compounds had significant inhibitory activity against Botrytis cinerea. EC 50The values ​​were 0.540, 0.676 and 0.392 μg / mL respectively. Their inhibitory effects were better than those of the marketed drug fluopyram (EC 50 =0.791 μg / mL).

[0011] In 2022, Lv et al. designed and synthesized a series of oxazole-containing pyrazol-5-ylbenzamide derivatives as potential SDH inhibitors. According to the results of bioassays, most of the target compounds showed moderate to excellent in vitro antifungal activity against apple rot fungus, rapeseed disc, tobacco red spot pathogen, and gray mold.

[0012] From the above studies, it can be seen that derivatives containing indole and pyrazole groups have good application prospects and have good biological activities in antibacterial and anti-tumor aspects. Summary of the invention

[0013] In order to solve the technical problems existing in the prior art, the purpose of the present invention is to provide a class of 3-substituted-1-H-indolepyrazole derivative compounds and their preparation methods and applications. The compounds have few synthesis steps, readily available synthetic raw materials, and a simple synthesis method. The compounds have good biological activity against a variety of plant pathogens such as rice bacterial blight, citrus canker, kiwi fruit canker, and tobacco bacterial wilt, and also have good activity against tumor cells.

[0014] In order to achieve the above purpose and the above technical effect, the technical solution adopted by the present invention is:

[0015] A class of 3-substituted-1-H-indole pyrazole derivative compounds, the structure of which is as follows:

[0016] Specifically, the structure is shown in the general formula (I-III):

[0017]

[0018] Among them, R1 is a single substitution or one or more substitutions of halogen, alkoxy, alkyl, trifluoromethyl, trifluoromethoxy, phenoxy or nitro; R2 is a single substitution or one or more substitutions of alkyl, halogen-substituted phenyl or pyridine or pyrimidine, alkoxy-substituted phenyl or pyridine or pyrimidine, nitro, substituted benzyl; R3 is a single substitution or one or more substitutions of halogen, alkoxy, alkyl, trifluoromethyl, trifluoromethoxy, amino or nitro; X=S / O.

[0019] Preferably, R1 is C1-C6 alkyl, halogen, trifluoromethyl, trifluoromethoxy, C1-C6 alkoxy, nitro, alkoxy, phenoxy; R2 is C1-C6 alkyl, halogen-substituted phenyl or pyridine or pyrimidine, trifluoromethyl-substituted phenyl or pyridine or pyrimidine, trifluoromethoxy-substituted phenyl or pyridine or pyrimidine, C1-C6 alkoxy-substituted phenyl or pyridine or pyrimidine, nitro-substituted benzyl; R3 is alkyl, halogen, trifluoromethyl, trifluoromethoxy, C1-C6 alkoxy, nitro, alkoxy;

[0020] Furthermore, the 3-substituted-1-H-indolepyrazole derivative compound is selected from the following compounds:

[0021]

[0022] The present invention also discloses a method for preparing a class of 3-substituted-1-H-indolepyrazole derivative compounds, comprising the following steps:

[0023]

[0024] The present invention also discloses a composition, comprising the compound or its stereoisomer, or its salt or solvate as described above, and an adjuvant or fungicide, insecticide or herbicide usable in agriculture, wherein the composition is in the form of emulsifiable concentrate (EC), dust (DP), wettable powder (WP), granule (GR), aqueous solution (AS), suspension (SC), ultra low volume spray (ULV), soluble powder (SP), microcapsule (MC), smoke concentrate (FU), emulsion in water (EW), and water dispersible granule (WG).

[0025] The compound or the composition is used in the preparation of drugs for preventing and controlling agricultural pests and diseases and anti-tumor drugs.

[0026] The agricultural pests and diseases are plant bacterial or fungal diseases.

[0027] The agricultural pests and diseases are rice bacterial blight, citrus canker, kiwi fruit canker, and tobacco bacterial wilt; the tumors are K562 (chronic myeloid leukemia cells), A549 (human non-small cell lung cancer cells), PC-3 (human prostate cancer cells), and 5637 (human bladder cancer cells).

[0028] The present invention also provides a method for preventing and controlling agricultural pests and diseases, wherein the compound or its stereoisomer, or its salt or solvate, or the composition acts on the harmful substance or its living environment.

[0029] The present invention also provides a method for protecting plants from agricultural pests and diseases, comprising the step of contacting the plants with the compound or its stereoisomer, or its salt or solvate, or the composition.

[0030] Compared with the prior art, the present invention has the following beneficial effects:

[0031] The invention is based on the indole structure substituted with pyrazole at the 3rd position to synthesize a series of indole compounds. The compounds have good inhibitory effects on pathogenic bacteria, and have good inhibitory effects on pathogenic bacteria such as rice bacterial blight, citrus canker, kiwi fruit bacterial canker, tobacco bacterial wilt and the like; and have good inhibitory effects on tumor cells such as K562 (chronic myeloid leukemia cells), A549 (human non-small cell lung cancer cells), PC-3 (human prostate cancer cells), 5637 (human bladder cancer cells), etc., providing an important scientific basis for the research and development and creation of new pesticides and medicines. DETAILED DESCRIPTION

[0032] A method for preparing a derivative compound of 5-(1H-indol-3-yl)-2H-pyrazole-3-amine comprises the following steps:

[0033] Solution 1

[0034]

[0035] First, indole (42.68 mmol) and cyanoacetic acid (59.75 mmol) were weighed and acetic anhydride was added as solvent. The mixture was reacted at 40°C for 5 h. After the reaction, the reaction solution was cooled and filtered, washed with methanol several times, and dried to obtain compound 2.

[0036] Weigh 5 g of compound 2 and add 30 ml of hydrazine hydrate as a reactant and solvent. React at 90° C. for 6 h. After the reaction is completed, cool the reaction solution and pour it into ice water. Stir for 20 min and then filter it. Wash it with ethyl acetate several times and dry it to obtain compound 3.

[0037] Add 1,4-dioxane as a reaction solvent to compound 3 (10.09 mmol) and Na2CO3 (16.14 mmol), stir for 10 min in an ice bath, then add dropwise 4 ml of dissolved hepatochloroacetate (8.07 mmol). After reacting for 5-6 h, slowly add dropwise the reaction solution into 300 ml of ice water, stir for 30 min, filter by suction, dry the solid, heat with ethanol at 80°C for about 40 min, filter while hot, and wash with ethanol to obtain compound 4.

[0038] 1,3,4-thiadiazole (1 eq) and differently substituted isocyanates (2 eq) were reacted at 80°C with acetonitrile as solvent for 5-6 hours. The reaction solution was cooled and filtered, washed with acetonitrile for several times, and dried to obtain compound D.

[0039] Compound 5 was reacted with compound 4 in anhydrous ethanol at 60° C. for 6-8 h to obtain the target product.

[0040] Example 1

[0041] Synthesis of E1:

[0042] p-Toluene isocyanate was reacted with 1,3,4-thiadiazole to obtain D1. Compound D1 (750.93 μmol) and KOH (1.5 mmol) were stirred in anhydrous ethanol at 60 °C for 30 min. Compound 4 (750.93 μmol) and KI (187.73 μmol) were stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above heating reaction. The reaction was continued for 6-8 h and then directly filtered and washed with ethanol to obtain compound E1.

[0043] Example 2

[0044] Synthesis of E2:

[0045] p-Chlorophenyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D2. Compound D2 (728.05 μmol) and KOH (1.46 mmol) were stirred in anhydrous ethanol at 60°C for 30 min. Compound 4 (728.05 μmol) and KI (182.01 μmol) were stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above-mentioned heating reaction. After the reaction was continued for 6-8 h, the mixture was added dropwise to 150 ml of ice sodium chloride water. The solid was then filtered, heated with methanol for 45 min, hot filtered, and washed with methanol for several times to obtain the target compound E2.

[0046] Example 3

[0047] Synthesis of E3:

[0048] m-Toluene isocyanate is reacted with 1,3,4-thiadiazole to obtain D3. Compound D3 (750.93 μmol) and KOH (1.5 mmol) are stirred in anhydrous ethanol at 60 °C for 30 min. At the same time, compound 4 (750.93 μmol) and KI (187.73 μmol) are stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above heating reaction. The reaction is continued for 6-8 h, then cooled and filtered, and washed with ethanol several times to obtain the target compound E3.

[0049] Example 4

[0050] Synthesis of E4:

[0051] 3-Chlorophenyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D4. Compound D4 (698.92 μmol) and KOH (1.4 mmol) were stirred in anhydrous ethanol at 60 °C for 30 min. Meanwhile, compound 4 (698.92 μmol) and KI (174.73 μmol) were stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above-mentioned heating reaction. The reaction was continued for 6-8 h, then cooled and filtered, and washed with ethanol for several times to obtain the target compound E4.

[0052] Example 5

[0053] Synthesis of E5:

[0054] Phenyl 3-fluoroisocyanate was reacted with 1,3,4-thiadiazole to obtain D5. Compound D5 (698.92 μmol) and KOH (1.4 mmol) were stirred in anhydrous ethanol at 60 °C for 30 min. Compound 4 (698.92 μmol) and KI (174.73 μmol) were stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above heating reaction. The reaction was continued for 6-8 h, then cooled and filtered, washed with ethanol several times, and dried to obtain the target compound E5.

[0055] Example 6

[0056] Synthesis of E6:

[0057] 2,4-Difluorophenyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D6. Compound D6 (589.68 μmol) and KOH (1.18 mmol) were stirred in anhydrous ethanol at 60°C for 30 min, and compound 4 (589.68 μmol) was added. The reaction was continued for 6-8 h, and then the mixture was added dropwise to ice water. The mixture was placed in a refrigerator for 30 min, and the solid was filtered, washed with ethanol for several times, and dried to obtain the target compound E6.

[0058] Example 7

[0059] Synthesis of E7:

[0060] 5-Chloro-2-methylphenyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D7. Compound D7 (664.94 μmol) and KOH (1.33 mmol) were stirred in anhydrous ethanol at 60 °C for 30 min, and compound 4 (664.94 μmol) was added. The reaction was continued for 6-8 h, and then cooled and filtered, washed with ethanol for several times, and dried to obtain the target compound E7.

[0061] Example 8

[0062] Synthesis of E8:

[0063] 2-(Trifluoromethyl)phenyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D8. Compound D8 (624.40 μmol) and KOH (1.25 mmol) were stirred in anhydrous ethanol at 60 °C for 30 min, and compound 4 (624.40 μmol) was added. The reaction was continued for 6-8 h, and then cooled and filtered, washed with ethanol for several times, and dried to obtain the target compound E8.

[0064] Example 9

[0065] Synthesis of E9:

[0066] 4-Trifluoromethylphenyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D9. Compound D9 (728.05 μmol) and KOH (1.46 mmol) were stirred in anhydrous ethanol at 60 °C for 30 min, and then compound 4 (728.05 μmol) was added. The reaction was continued for 6-8 h, and then cooled and filtered, washed with ethanol for several times, and dried to obtain the target compound E9.

[0067] Example 10

[0068] Synthesis of E10:

[0069] 4-Chloro-3-trifluoromethylphenyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D10. Compound D10 (845.67 μmol) and KOH (1.69 mmol) were stirred in anhydrous ethanol at 60°C for 30 min, and compound 4 (845.67 μmol) was added. The reaction was continued for 6-8 h, and then cooled and added dropwise to ice water. The mixture was placed in a refrigerator overnight, filtered, and purified with ethanol to obtain the target compound E10.

[0070] Embodiment 11

[0071] Synthesis of E11:

[0072] 4-Bromophenyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D11. Compound D11 (1.46 mmol) and KOH (2.91 mmol) were stirred in anhydrous ethanol at 60°C for 30 min. Meanwhile, compound 4 (1.46 mmol) and KI (364.02 μmol) were stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above-mentioned heating reaction. The reaction was continued for 6-8 h, and then added dropwise to 50 ml of ice brine. The mixture was filtered by suction. After the solid was dried, it was hot-filtered with methanol and ethanol to obtain the target compound E11.

[0073] Example 12

[0074] Synthesis of E12:

[0075] 3-Trifluoromethylphenylisocyanate was reacted with 1,3,4-thiadiazole to obtain D12. Compound D12 (1.46 mmol) and KOH (2.91 mmol) were stirred in anhydrous ethanol at 60 °C for 30 min. At the same time, compound 4 (1.46 mmol) and KI (364.02 μmol) were stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above heating reaction. The reaction was continued for 6-8 h, cooled, filtered, and dried to obtain the target compound E12.

[0076] Embodiment 13

[0077] Synthesis of E13:

[0078] o-Toluene isocyanate is reacted with 1,3,4-thiadiazole to obtain D13. Compound D13 (1.46 mmol) and KOH (2.91 mmol) are stirred in anhydrous ethanol at 60°C for 30 min. Meanwhile, compound 4 (1.46 mmol) and KI (364.02 μmol) are stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above heating reaction. The reaction is continued for 6-8 h. The mixture is cooled and added dropwise to 50 ml of ice brine and stirred for half an hour. The mixture is filtered after suction. After the solid is dried, it is heated at 80°C with anhydrous ethanol for 1 h and then filtered hot. The target compound E13 is obtained after washing with ethanol for several times and drying.

[0079] Embodiment 14

[0080] Synthesis of E14:

[0081] p-Fluorophenyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D14. Compound D14 (1.46 mmol) and KOH (2.91 mmol) were stirred in anhydrous ethanol at 60°C for 30 min. Meanwhile, compound 4 (1.46 mmol) and KI (364.02 μmol) were stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above heating reaction. The reaction was continued for 6-8 h. The mixture was cooled and added dropwise to 50 ml of ice brine and stirred for half an hour. The mixture was filtered after suction. After the solid was dried, it was heated at 80°C with anhydrous ethanol for 1 h and then filtered hot. The target compound E14 was obtained after washing with ethanol for several times and drying.

[0082] Embodiment 15

[0083] Synthesis of E15:

[0084] 4-Trifluoromethoxyphenyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D15. Compound D15 (1.46 mmol) and KOH (2.91 mmol) were stirred in anhydrous ethanol at 60°C for 30 min. Meanwhile, compound 4 (1.46 mmol) and KI (364.02 μmol) were stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above heating reaction. The reaction was continued for 6-8 h. The mixture was cooled and added dropwise to 50 ml of ice brine, stirred for half an hour and then filtered. After the solid was dried, it was heated at 80°C with anhydrous ethanol for 1-2 h and then filtered hot. The target compound E15 was obtained after washing with ethanol for several times and drying.

[0085] Example 16

[0086] Synthesis of E16:

[0087] 4-Cyanophenyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D16. Compound D16 (1.46 mmol) and KOH (2.91 mmol) were stirred in anhydrous ethanol at 60°C for 30 min. Meanwhile, compound 4 (1.46 mmol) and KI (364.02 μmol) were stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above heating reaction. The reaction was continued for 6-8 h. The mixture was cooled and added dropwise to 50 ml of ice brine and stirred for half an hour. The mixture was filtered and the solid was dried. The solid was heated at 80°C with anhydrous ethanol for 1-2 h and then filtered. The above purification steps were repeated several times and then dried to obtain the target compound E16.

[0088] Embodiment 17

[0089] Synthesis of E17:

[0090] 2-Nitrophenyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D17. Compound D17 (1.46 mmol) and KOH (2.91 mmol) were stirred in anhydrous ethanol at 60 °C for 30 min. Meanwhile, compound 4 (1.46 mmol) and KI (364.02 μmol) were stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above heating reaction. The reaction was continued for 6-8 h, cooled, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound E17.

[0091] Embodiment 18

[0092] Synthesis of E18:

[0093] 3,5-Dichlorophenyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D18. Compound D18 (1.46 mmol) and KOH (2.91 mmol) were stirred in anhydrous ethanol at 60°C for 30 min. Meanwhile, compound 4 (1.46 mmol) and KI (364.02 μmol) were stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above heating reaction. The reaction was continued for 6-8 h, cooled, added dropwise to ice-salt water, stirred for half an hour, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound E18.

[0094] Embodiment 19

[0095] Synthesis of E19:

[0096] 2-Bromophenyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D19. Compound D19 (1.46 mmol) and KOH (2.91 mmol) were stirred in anhydrous ethanol at 60 °C for 30 min. At the same time, compound 4 (1.46 mmol) and KI (364.02 μmol) were stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above heating reaction. The reaction was continued for 6-8 h, cooled, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound E19.

[0097] Embodiment 20

[0098] Synthesis of E20:

[0099] 2,4-Dichlorophenyl isocyanate is reacted with 1,3,4-thiadiazole to obtain D20. Compound D20 (1.46 mmol) and KOH (2.91 mmol) are stirred in anhydrous ethanol at 60°C for 30 min. Meanwhile, compound 4 (1.46 mmol) and KI (364.02 μmol) are stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above-mentioned heating reaction. The reaction is continued for 6-8 h. The mixture is cooled and added dropwise to 50 ml of ice brine and stirred for half an hour. The mixture is filtered after suction. After drying, anhydrous ethanol is added to reflux for 1-2 h and then filtered while hot. The mixture is washed with anhydrous ethanol for several times and dried to obtain the target compound E20.

[0100] Embodiment 21

[0101] Synthesis of E21:

[0102] Benzyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D21. Compound D21 (1.46 mmol) and KOH (2.91 mmol) were stirred in anhydrous ethanol at 60 °C for 30 min. Compound 4 (1.46 mmol) and KI (364.02 μmol) were stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above heating reaction. The reaction was continued for 6-8 h, cooled, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound E21.

[0103] Embodiment 22

[0104] Synthesis of E22:

[0105] 4-Methoxyphenyl isocyanate is reacted with 1,3,4-thiadiazole to obtain D22. Compound D22 (1.46 mmol) and KOH (2.91 mmol) are stirred in anhydrous ethanol at 60°C for 30 min. At the same time, compound 4 (1.46 mmol) and KI (364.02 μmol) are stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above heating reaction. The reaction is continued for 6-8 h, cooled, and added dropwise to 50 ml of ice brine. After half an hour, it is filtered and dried. After heating to reflux with anhydrous ethanol and methanol, it is filtered while hot, washed several times, and dried to obtain the target compound E22.

[0106] Embodiment 23

[0107] Synthesis of E23:

[0108] 3-Nitrophenyl isocyanate was reacted with 1,3,4-thiadiazole to obtain D23. Compound D23 (1.46 mmol) and KOH (2.91 mmol) were stirred in anhydrous ethanol at 60 °C for 30 min. Meanwhile, compound 4 (1.46 mmol) and KI (364.02 μmol) were stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above heating reaction. The reaction was continued for 6-8 h, cooled, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound E23.

[0109] Embodiment 24

[0110] Synthesis of E24:

[0111] 2-Methoxyphenyl isocyanate is reacted with 1,3,4-thiadiazole to obtain D24. Compound D24 (1.46 mmol) and KOH (2.91 mmol) are stirred in anhydrous ethanol at 60°C for 30 min. Meanwhile, compound 4 (1.46 mmol) and KI (364.02 μmol) are stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above-mentioned heating reaction. The reaction is continued for 6-8 h. The mixture is cooled and added dropwise to 50 ml of ice brine and stirred for half an hour. The mixture is filtered and dried. The mixture is heated to reflux with methanol and filtered while hot. The mixture is washed with methanol for several times and dried to obtain the target compound E24.

[0112] Embodiment 25

[0113] Synthesis of E25:

[0114] 4-Phenoxyphenylisocyanate is reacted with 1,3,4-thiadiazole to obtain D25. Compound D25 (1.46 mmol) and KOH (2.91 mmol) are stirred in anhydrous ethanol at 60°C for 30 min. At the same time, compound 4 (1.46 mmol) and KI (364.02 μmol) are stirred in anhydrous ethanol at room temperature for 30 min and then added dropwise to the above heating reaction. The reaction is continued for 6-8 h. The mixture is cooled and added dropwise to 50 ml of ice brine and stirred for half an hour. The mixture is filtered and dried. The mixture is heated to reflux with methanol and filtered while hot. The mixture is washed with methanol for several times and dried to obtain the target compound E25.

[0115] The physicochemical properties and H NMR and C NMR data of the derivatives of 5-(1H-indol-3-yl)-2H-pyrazol-3-amine are shown in Table 1 Table 1 shows the physicochemical properties and H NMR data of the target compounds.

[0116] Table 1

[0117]

[0118]

[0119]

[0120]

[0121]

[0122]

[0123]

[0124] Solution 2

[0125]

[0126] First, indole (42.68 mmol) and cyanoacetic acid (59.75 mmol) were weighed and acetic anhydride was added as solvent. The mixture was reacted at 40°C for 5 h. After the reaction, the reaction solution was cooled and filtered, washed with methanol for several times, and dried to obtain compound 2.

[0127] Weigh 5 g of compound 2 and add 30 ml of hydrazine hydrate as a reactant and solvent. React at 90° C. for 6 h. After the reaction is completed, cool the reaction solution and pour it into ice water. Stir for 20 min and then filter it. Wash it with ethyl acetate several times and dry it to obtain compound 3.

[0128] Add 1,4-dioxane as a reaction solvent to compound 3 (10.09 mmol) and Na2CO3 (16.14 mmol), stir for 10 min in an ice bath, then add dropwise 4 ml of dissolved hepatochloroacetate (8.07 mmol). After reacting for 5-6 h, slowly add dropwise the reaction solution into 300 ml of ice water, stir for 30 min, filter by suction, dry the solid, heat with ethanol at 80°C for about 40 min, filter while hot, and wash with ethanol to obtain compound 4.

[0129] Compound 4 (1 eq) was reacted with differently substituted piperazine (1.5 eq) in anhydrous ethanol to obtain the target compound F.

[0130] Embodiment 26

[0131] Synthesis of F1:

[0132] 0.15 g of compound 4 (546.03 μmol), 0.106 g of 1-phenylpiperazine (655.24 μmol), and 0.15 g of K2CO3 (1.09 mmol) were weighed and placed in a 50 mL round-bottom flask. A solvent of acetonitrile: anhydrous ethanol = 1:1 was added. After reacting at room temperature for 48 h, the reaction solution was allowed to stand for 48 h. Solid precipitated, which was filtered and dried to obtain the target compound F1.

[0133] Embodiment 27

[0134] Synthesis of F2:

[0135] Weigh 0.15 g of compound 4 (546.03 μmol), 0.135 g of 1-phenylpiperazine (819.05 μmol), and 0.15 g of K2CO3 (1.09 mmol) into a 50 mL round-bottom flask, add anhydrous ethanol as solvent, react at room temperature for 48 h, spin dry the reaction solution, stir with dichloromethane at room temperature for 2 h and filter, purify with dichloromethane several times and dry to obtain the target compound F2.

[0136] Embodiment 28

[0137] Synthesis of F3:

[0138] 0.3 g of compound 4 (1.09 mmol), 0.292 g of 4-(1-piperazinyl)phenol (1.64 mmol), and 0.3 g of K2CO3 (2.18 mmol) were weighed and placed in a 50 mL round-bottom flask, and anhydrous ethanol solvent was added. After reacting at room temperature for 48 h, the reaction solution was spin-dried and purified by column chromatography to obtain the target compound F3.

[0139] Embodiment 29

[0140] Synthesis of F4:

[0141] 0.3 g of compound 4 (1.09 mmol), 0.276 g of 1-cyclohexylpiperazine (1.64 mmol), and 0.3 g of K2CO3 (2.18 mmol) were weighed and placed in a 50 mL round-bottom flask, and a solvent of acetonitrile: anhydrous ethanol = 1:1 was added. After reacting at room temperature for 48 h, the reaction solution was spin-dried, stirred with dichloromethane at room temperature for 2 h, and then filtered. After multiple purifications with dichloromethane, the target compound F4 was obtained by drying.

[0142] Embodiment 30

[0143] Synthesis of F5:

[0144] 0.3 g of compound 4 (1.09 mmol), 0.324 g of difluorophenylpiperazine (1.64 mmol), and 0.3 g of K2CO3 (2.18 mmol) were weighed and placed in a 50 mL round-bottom flask, and a solvent of acetonitrile: anhydrous ethanol = 1:1 was added. After reacting at room temperature for 48 h, the reaction solution was spin-dried, stirred with dichloromethane at room temperature for 2 h and then filtered. After multiple purifications with dichloromethane, the target compound F5 was obtained by drying.

[0145] Embodiment 31

[0146] Synthesis of F6:

[0147] 0.339 g of 1-(4-nitrophenyl)piperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as a solvent. After reflux at 80°C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above-mentioned heating reaction. After reacting for 7 h, the mixture was filtered, stirred at room temperature with dichloromethane, anhydrous ethanol, and a mixed solvent of anhydrous ethanol and tetrahydrofuran, filtered, and dried to obtain the target compound F6.

[0148] Embodiment 32

[0149] Synthesis of F7:

[0150] 0.307 g of 1-(4-cyanophenyl)piperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as solvent. After reflux at 80 °C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above-mentioned heating reaction. After reacting for 7 h, the mixture was cooled, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound F7.

[0151] Embodiment 33

[0152] Synthesis of F8:

[0153] 0.322 g of 1-(4-chlorophenyl)piperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as solvent. After reflux at 80 °C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above heating reaction. After reacting for 7 h, the mixture was cooled, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound F8.

[0154] Embodiment 34

[0155] Synthesis of F9:

[0156] 0.322 g of 5-bromo-2-(4-methylpiperazin-1-yl)pyrimidine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as a solvent. After reflux at 80°C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above heating reaction. After reacting for 7 h, the mixture was cooled, added dropwise to ice-salt water, stirred for 30 min, and then filtered. The solid was dried and stirred with dichloromethane at room temperature for 4 h, then filtered, washed with dichloromethane for several times, and dried to obtain the target compound F9.

[0157] Embodiment 35

[0158] Synthesis of F10:

[0159] 0.395 g of 1-(4-bromophenyl)piperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and placed in a 50 mL round-bottom flask, and anhydrous ethanol was added as the solvent. After reflux at 80 °C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above-mentioned heating reaction. After reacting for 7 h, the mixture was cooled, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound F10.

[0160] Embodiment 36

[0161] Synthesis of F11:

[0162] 0.289 g of 1-(4-methylphenyl)piperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as solvent. After reflux at 80 °C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above heating reaction. After reacting for 7 h, the mixture was cooled, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound F11.

[0163] Embodiment 37

[0164] Synthesis of F12:

[0165] 0.315 g of 1-(3-methoxyphenyl)piperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as solvent. After reflux at 80 °C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above-mentioned heating reaction. After reacting for 7 h, the mixture was cooled, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound F12.

[0166] Embodiment 38

[0167] Synthesis of F13:

[0168] 0.295 g of 1-(4-fluorophenyl)piperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as solvent. After reflux at 80 °C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above heating reaction. After reacting for 7 h, the mixture was cooled, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound F13.

[0169] Embodiment 39

[0170] Synthesis of F14:

[0171] 0.289 g of 1-(2-methylphenyl)piperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as solvent. After reflux at 80 °C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above heating reaction. After reacting for 7 h, the mixture was cooled, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound F14.

[0172] Embodiment 40

[0173] Synthesis of F15:

[0174] 0.289 g of 1-(3-methylphenyl)piperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as solvent. After reflux at 80 °C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above-mentioned heating reaction. After reacting for 7 h, the mixture was cooled, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound F15.

[0175] Embodiment 41

[0176] Synthesis of F16:

[0177] 0.345 g of 1-(4-chlorobenzyl)piperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as the solvent. After reflux at 80°C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above heating reaction. After reacting for 7 h, the mixture was cooled, added dropwise to ice-salt water, filtered, and dried. The solid was stirred for 5 h at room temperature with dichloromethane and anhydrous ethanol, filtered, washed several times, and dried to obtain the target compound F16.

[0178] Embodiment 42

[0179] Synthesis of F17:

[0180] 0.339 g of 1-(2-nitrophenyl)piperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as solvent. After reflux at 80 °C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above heating reaction. After reacting for 7 h, the mixture was cooled, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound F17.

[0181] Embodiment 43

[0182] Synthesis of F18:

[0183] 0.187 g of N-ethylpiperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as the solvent. After reflux at 80 °C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above-mentioned heating reaction. After reacting for 7 h, the mixture was spin-dried and purified by column chromatography to obtain the target compound F18.

[0184] Embodiment 44

[0185] Synthesis of F19:

[0186] 0.379 g of 1-[5-(trifluoromethyl)-2-pyridyl]piperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as the solvent. After reflux at 80°C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above heating reaction. After reacting for 7 h, the mixture was cooled, added dropwise to ice-salt water, filtered, and dried. The solid was purified by dichloromethane and anhydrous ethanol, and dried to obtain the target compound F19.

[0187] Embodiment 45

[0188] Synthesis of F20:

[0189] 0.379 g of 1-(3,4-dichlorophenyl)piperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as solvent. After reflux at 80 °C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above heating reaction. After reacting for 7 h, the mixture was cooled, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound F20.

[0190] Embodiment 46

[0191] Synthesis of F21:

[0192] 0.377 g of 1-(4-trifluoromethylphenyl)piperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as solvent. After reflux at 80 °C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above-mentioned heating reaction. After reacting for 7 h, the mixture was cooled, filtered, washed with anhydrous ethanol for several times, and dried to obtain the target compound F21.

[0193] Embodiment 47

[0194] Synthesis of F22:

[0195] 0.219 g of N-methylpiperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as the solvent. After reflux at 80 °C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above-mentioned heating reaction. After reacting for 7 h, the mixture was spin-dried and purified by column chromatography to obtain the target compound F22.

[0196] Embodiment 48

[0197] Synthesis of F23:

[0198] 0.280 g of N-isopropylpiperazine (1.64 mmol) and 0.123 g of KOH (2.18 mmol) were weighed and put into a 50 mL round-bottom flask, and anhydrous ethanol was added as the solvent. After reflux at 80 °C for 30 min, 0.3 g of compound 4 (1.09 mmol) and 0.045 g of KI (273.02 μmol) were weighed at the same time, anhydrous ethanol was added at room temperature, stirred for 30 min, and then added dropwise to the above-mentioned heating reaction. After reacting for 7 h, the mixture was spin-dried and purified by column chromatography to obtain the target compound F23.

[0199] The physicochemical properties and H NMR and C NMR data of some synthesized piperazine-containing indole derivatives are shown in Table 2 Table 2 shows the physicochemical properties and H NMR data of the target compounds.

[0200] Table 2

[0201]

[0202]

[0203]

[0204]

[0205] Solution 3

[0206]

[0207] First, indole (42.68 mmol) and cyanoacetic acid (59.75 mmol) were weighed and acetic anhydride was added as solvent. The mixture was reacted at 40°C for 5 h. After the reaction, the reaction solution was cooled and filtered, washed with methanol several times, and dried to obtain compound 2.

[0208] Weigh 5 g of compound 2 and add 30 ml of hydrazine hydrate as a reactant and solvent. React at 90° C. for 6 h. After the reaction is completed, cool the reaction solution and pour it into ice water. Stir for 20 min and then filter it. Wash it with ethyl acetate several times and dry it to obtain compound 3.

[0209] Add 1,4-dioxane as a reaction solvent to compound 3 (10.09 mmol) and Na2CO3 (16.14 mmol), stir for 10 min in an ice bath, then add dropwise 4 ml of dissolved hepatochloroacetate (8.07 mmol). After reacting for 5-6 h, slowly add dropwise the reaction solution into 300 ml of ice water, stir for 30 min, filter by suction, dry the solid, heat with ethanol at 80°C for about 40 min, filter while hot, and wash with ethanol to obtain compound 4.

[0210] Intermediate 4 (1.09 mmol) and potassium hydroxide (2.18 mmol) were dissolved in anhydrous ethanol (5 mL). The mixture was heated at room temperature or at 80°C for 30 min, and then different substituted or unsubstituted thiophenols (1.31 mmol) were added to react for 3-8 h. The reaction solution was poured into ice water, stirred, and filtered, and washed with anhydrous ethanol to obtain the target compound S.

[0211] Embodiment 49

[0212] Synthesis of S1:

[0213] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and 3-chlorobenzenethiol (1.31 mmol) was added to continue the reaction for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.31 g S1.

[0214] Embodiment 550

[0215] Synthesis of S2:

[0216] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask. 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min. 3-Fluorobenzenethiol (1.31 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.31 g S2.

[0217] Embodiment 51

[0218] Synthesis of S3:

[0219] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask. 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min. 3-bromobenzenethiol (1.31 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.31 g S3.

[0220] Embodiment 52

[0221] Synthesis of S4:

[0222] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and 2-methoxybenzenethiol (1.31 mmol) was added to continue the reaction for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.32 g S4.

[0223] Embodiment 53

[0224] Synthesis of S5:

[0225] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and 2-bromobenzenethiol (1.31 mmol) was added to continue the reaction for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.3 g S5.

[0226] Embodiment 54

[0227] Synthesis of S6:

[0228] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and 4-fluorobenzenethiol (1.31 mmol) was added to continue the reaction for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.36 g S6.

[0229] Embodiment 55

[0230] Synthesis of S7:

[0231] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and then 4-nitrobenzenethiol (1.31 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.32 g S7.

[0232] Embodiment 56

[0233] Synthesis of S8:

[0234] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and 4-methylthiophenol (1.31 mmol) was added to continue the reaction for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.3 g S8.

[0235] Embodiment 57

[0236] Synthesis of S9:

[0237] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and 4-trifluoromethylbenzenethiol (1.31 mmol) was added to continue the reaction for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.32 g S9.

[0238] Embodiment 58

[0239] Synthesis of S10:

[0240] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and reacted at room temperature for 30 min, then 3-aminobenzenethiol (1.31 mmol) was added and the reaction was continued for 5 h to overnight. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.34 g S10.

[0241] Embodiment 59

[0242] Synthesis of S11:

[0243] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and reacted at room temperature for 30 min, and then 4-aminobenzenethiol (1.31 mmol) was added to continue the reaction for 9 minutes. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.31 g S11.

[0244] Embodiment 60

[0245] Synthesis of S12:

[0246] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and 2-fluorobenzenethiol (1.31 mmol) was added to continue the reaction for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.35 g S12.

[0247] Embodiment 61

[0248] Synthesis of S13:

[0249] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and then 2-chlorobenzenethiol (1.31 mmol) was added to continue the reaction for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.32 g S13.

[0250] Embodiment 62

[0251] Synthesis of S14:

[0252] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and then 2-trifluoromethylbenzenethiol (1.31 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.34 g S14.

[0253] Embodiment 63

[0254] Synthesis of S15:

[0255] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and 3-trifluoromethylthiophenol (1.31 mmol) was added to continue the reaction for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.33 g S15.

[0256] Embodiment 64

[0257] Synthesis of S16:

[0258] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and 2-aminobenzenethiol (1.31 mmol) was added to continue the reaction for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.31 g S16.

[0259] Embodiment 65

[0260] Synthesis of S17:

[0261] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and 4-methoxybenzenethiol (1.31 mmol) was added to continue the reaction for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.31 g S1.

[0262] Embodiment 66

[0263] Synthesis of S18:

[0264] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and 3-chlorobenzenethiol (1.31 mmol) was added to continue the reaction for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.32 g S1.

[0265] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and 4-chlorobenzenethiol (1.31 mmol) was added to continue the reaction for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.29 g S18.

[0266] Embodiment 67

[0267] Synthesis of S19:

[0268] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask. 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min. 3-Methylthiophenol (1.31 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.31 g S19.

[0269] Embodiment 68

[0270] Synthesis of S20:

[0271] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 ° C for 30 min, and 4-methylthiophenol (1.31 mmol) was added to continue the reaction for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.3 g S20.

[0272] Embodiment 69

[0273] Synthesis of S21:

[0274] 0.3 g of intermediate 3 (1.09 mmol) and 0.12 g of potassium hydroxide (2.18 mmol) were weighed and put into a 25 mL round-bottom flask, 5 mL of anhydrous ethanol was added and heated at 80 °C for 30 min, and 4-bromobenzenethiol (1.31 mmol) was added to continue the reaction for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water with stirring, filtered, washed with a small amount of anhydrous ethanol and dried to obtain the target product 0.32 g S21.

[0275] The physicochemical properties and H NMR and C NMR data of some of the synthesized compounds containing 3-substituted-1-H-indolepyrazole derivatives are shown in Table 3 , which shows the physicochemical properties and H NMR data of the target compounds.

[0276] Table 3

[0277]

[0278]

[0279]

[0280]

[0281] Solution 4

[0282]

[0283] First, indole (42.68 mmol) and cyanoacetic acid (59.75 mmol) were weighed and acetic anhydride was added as solvent. The mixture was reacted at 40°C for 5 h. After the reaction, the reaction solution was cooled and filtered, washed with methanol for several times, and dried to obtain compound 2.

[0284] Weigh 5 g of compound 2 and add 30 ml of hydrazine hydrate as a reactant and solvent. React at 90° C. for 6 h. After the reaction is completed, cool the reaction solution and pour it into ice water. Stir for 20 min and then filter it. Wash it with ethyl acetate several times and dry it to obtain compound 3.

[0285] Add 1,4-dioxane as a reaction solvent to compound 3 (10.09 mmol) and Na2CO3 (16.14 mmol), stir for 10 min in an ice bath, then add dropwise 4 ml of dissolved hepatochloroacetate (8.07 mmol). After reacting for 5-6 h, slowly add dropwise the reaction solution into 300 ml of ice water, stir for 30 min, filter by suction, dry the solid, heat with ethanol at 80°C for about 40 min, filter while hot, and wash with ethanol to obtain compound 4.

[0286] Intermediate 4 (1.46 mmol) and cesium carbonate (2.91 mmol) were dissolved in anhydrous ethanol (7 mL), heated at 80°C for 30 min, and then different substituted or unsubstituted phenols (2.18 mmol) were added to react for 5-8 h. The reaction solution was poured into ice water, stirred, and then filtered, washed with a small amount of anhydrous ethanol. After drying, the target compounds O1-O22 were purified by silica gel column chromatography.

[0287] Embodiment 70

[0288] Synthesis of O1:

[0289] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 ° C for 30 min. 4-fluorophenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product 0.26 g O1 was obtained by silica gel column chromatography purification (methanol: dichloromethane = 1:40).

[0290] Embodiment 71

[0291] Synthesis of O2:

[0292] Weigh 0.4g of intermediate 3 (1.46mmol) and 0.95g of cesium carbonate (2.91mmol) into a 25mL round-bottom flask, add 7mL of anhydrous ethanol, heat at 80℃ for 30min, add 3-chlorophenol (2.18mmol) and continue to react for 5h. After the reaction is completed, pour the reaction solution into a small amount of ice water, stir, filter, and wash with a small amount of anhydrous ethanol. After drying, purify by silica gel column chromatography (methanol: dichloromethane = 1:40) to obtain the target product 0.24g O2.

[0293] Embodiment 72

[0294] Synthesis of O3:

[0295] Weigh 0.4g of intermediate 3 (1.46mmol) and 0.95g of cesium carbonate (2.91mmol) into a 25mL round-bottom flask, add 7mL of anhydrous ethanol, heat and react at 80℃ for 30min, add 2-fluoro-4-methylphenol (2.18mmol) and continue to react for 5h. After the reaction, pour the reaction solution into a small amount of ice water, stir, filter, and wash with a small amount of anhydrous ethanol. After drying, purify by silica gel column chromatography (methanol: dichloromethane = 1:40) to obtain the target product 0.28g O3.

[0296] Embodiment 73

[0297] Synthesis of O4:

[0298] Weigh 0.4g of intermediate 3 (1.46mmol) and 0.95g of cesium carbonate (2.91mmol) into a 25mL round-bottom flask, add 7mL of anhydrous ethanol, heat at 80℃ for 30min, add 2,4-dibromophenol (2.18mmol) and continue to react for 5h. After the reaction, pour the reaction solution into a small amount of ice water, stir, filter, and wash with a small amount of anhydrous ethanol. After drying, purify by silica gel column chromatography (methanol: dichloromethane = 1:40) to obtain the target product 0.21g O4.

[0299] Embodiment 74

[0300] Synthesis of O5:

[0301] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 ° C for 30 min. 2-bromophenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product 0.18 g O5 was obtained by silica gel column chromatography purification (methanol: dichloromethane = 1:40).

[0302] Embodiment 75

[0303] Synthesis of O6:

[0304] Weigh 0.4g of intermediate 3 (1.46mmol) and 0.95g of cesium carbonate (2.91mmol) into a 25mL round-bottom flask, add 7mL of anhydrous ethanol, heat at 80℃ for 30min, add 2,5-dibromophenol (2.18mmol) and continue to react for 5h. After the reaction, pour the reaction solution into a small amount of ice water, stir, filter, and wash with a small amount of anhydrous ethanol. After drying, purify by silica gel column chromatography (methanol: dichloromethane = 1:40) to obtain 0.18g of the target product O6.

[0305] Embodiment 76

[0306] Synthesis of O7:

[0307] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 ° C for 30 min. 4-methoxyphenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product 0.22 g O7 was obtained by silica gel column chromatography purification (methanol: dichloromethane = 1:40).

[0308] Embodiment 77

[0309] Synthesis of O8:

[0310] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 ° C for 30 min. 3-chloro-4-methylphenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product 0.23 g O8 was obtained by silica gel column chromatography purification (methanol: dichloromethane = 1:40).

[0311] Embodiment 78

[0312] Synthesis of O9:

[0313] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 ° C for 30 min. 4-bromophenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product 0.19 g O9 was obtained by silica gel column chromatography purification (methanol: dichloromethane = 1:40).

[0314] Embodiment 79

[0315] Synthesis of O10:

[0316] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 °C for 30 min. 3,4-dimethylphenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product 0.25 g O10 was obtained by silica gel column chromatography purification (methanol: dichloromethane = 1:40).

[0317] Embodiment 80

[0318] O11 synthesis:

[0319] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 °C for 30 min. 2,4-dichloro-6-methylphenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water, stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product O11 was obtained by silica gel column chromatography purification (methanol: dichloromethane = 1:40) to obtain 0.28 g.

[0320] Embodiment 81

[0321] Synthesis of O12:

[0322] Weigh 0.4g of intermediate 3 (1.46mmol) and 0.95g of cesium carbonate (2.91mmol) into a 25mL round-bottom flask, add 7mL of anhydrous ethanol, heat at 80℃ for 30min, add 3-methoxyphenol (2.18mmol) and continue to react for 5h. After the reaction, pour the reaction solution into a small amount of ice water, stir, filter, and wash with a small amount of anhydrous ethanol. After drying, purify by silica gel column chromatography (methanol: dichloromethane = 1:40) to obtain 0.18g of the target product O12.

[0323] Embodiment 82

[0324] Synthesis of O13:

[0325] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 ° C for 30 min. 2,4-difluorophenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product 0.26 g O13 was obtained by silica gel column chromatography purification (methanol: dichloromethane = 1:40).

[0326] Embodiment 83

[0327] Synthesis of O14:

[0328] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 ° C for 30 min. 3-phenylphenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product 0.29 g O14 was obtained by silica gel column chromatography purification (methanol: dichloromethane = 1:40).

[0329] Embodiment 84

[0330] Synthesis of O15:

[0331] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 ° C for 30 min. 4-fluoro-3-methylphenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product 0.28 g O15 was obtained by silica gel column chromatography purification (methanol: dichloromethane = 1:40).

[0332] Embodiment 85

[0333] Synthesis of O16:

[0334] Weigh 0.4g of intermediate 3 (1.46mmol) and 0.95g of cesium carbonate (2.91mmol) into a 25mL round-bottom flask, add 7mL of anhydrous ethanol, heat at 80℃ for 30min, add 4-chloro-3-methylphenol (2.18mmol) and continue to react for 5h. After the reaction, pour the reaction solution into a small amount of ice water, stir, filter, and wash with a small amount of anhydrous ethanol. After drying, purify by silica gel column chromatography (methanol: dichloromethane = 1:40) to obtain 0.25g of the target product O16.

[0335] Embodiment 86

[0336] Synthesis of O17:

[0337] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 ° C for 30 min. 3-fluorophenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product O17 was purified by silica gel column chromatography (methanol: dichloromethane = 1:40) to obtain 0.24 g.

[0338] Embodiment 87

[0339] Synthesis of O18:

[0340] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 ° C for 30 min. 3,5-dimethylphenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product 0.27 g O18 was obtained by silica gel column chromatography purification (methanol: dichloromethane = 1:40).

[0341] Embodiment 88

[0342] Synthesis of O19:

[0343] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 ° C for 30 min. 4-chloro-2-methylphenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product 0.25 g O19 was obtained by silica gel column chromatography purification (methanol: dichloromethane = 1:40).

[0344] Embodiment 89

[0345] Synthesis of O20:

[0346] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 ° C for 30 min. 3-chloro-4-fluorophenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water, stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product 0.28 g O20 was obtained by silica gel column chromatography purification (methanol: dichloromethane = 1:40).

[0347] Embodiment 90

[0348] Synthesis of O21:

[0349] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 ° C for 30 min. 2-trifluoromethylphenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product 0.32 g O21 was obtained by silica gel column chromatography purification (methanol: dichloromethane = 1:40).

[0350] Embodiment 91

[0351] Synthesis of O22:

[0352] 0.4 g of intermediate 3 (1.46 mmol) and 0.95 g of cesium carbonate (2.91 mmol) were weighed and placed in a 25 mL round-bottom flask. 7 mL of anhydrous ethanol was added and heated at 80 ° C for 30 min. 3-trifluoromethylphenol (2.18 mmol) was added and the reaction was continued for 5 h. After the reaction was completed, the reaction solution was poured into a small amount of ice water and stirred, filtered, and washed with a small amount of anhydrous ethanol. After drying, the target product 0.31 g O22 was obtained by silica gel column chromatography purification (methanol: dichloromethane = 1:40).

[0353] The physicochemical properties and H NMR and C NMR data of some of the synthesized compounds containing 3-substituted-1-H-indolepyrazole derivatives are shown in Table 4 , which shows the physicochemical properties and H NMR data of the target compounds.

[0354] Table 4

[0355]

[0356]

[0357]

[0358]

[0359] Pharmacological Example 1:

[0360] Antitumor activity testing.

[0361] The MTT method is used to test the anti-tumor activity of the target compound. The full name of MTT is 3-(4,5)-dimethylthiahiazo(-z-y1)-3,5-di-phenytetrazoliumromide, and its Chinese chemical name is 3-(4,5-dimethylthiazol-2)-2,5-diphenyltetrazolium bromide (thiazolyl blue), which is a yellow dye. MTT colorimetry is a method for detecting cell survival and growth. Its detection principle is that succinate dehydrogenase in the mitochondria of living cells can reduce exogenous MTT to water-insoluble blue-purple crystalline formazan and deposit it in the cells, while dead cells do not have this function. Dimethyl sulfoxide (DMSO) can dissolve the formazan in the cells, and its light absorption value is measured at a wavelength of 490nm using an enzyme-linked immunosorbent assay, which can indirectly reflect the number of living cells. Within a certain range of cell numbers, the amount of MTT crystals formed is proportional to the number of cells.

[0362] Test cell lines

[0363] 5637 (human bladder cancer cell line, adherent cells);

[0364] A549 (human non-small cell lung cancer cells, adherent cells);

[0365] PC-3 (human prostate cancer cells, adherent cells);

[0366] T47D (human ductal breast carcinoma cell line);

[0367] K562 (human chronic myeloid leukemia cells, suspension cells).

[0368] Cell counting

[0369] First, soak the cell counting plate and blood cover with anhydrous ethanol; take 10μL of cell suspension and drip it on the edge of the blood cover, so that the suspension fills the space between the blood cover and the counting plate, and cannot overflow the blood cover or overflow into the glass grooves on both sides; observe the number of cells in the four large squares of the counting plate (each large square contains 16 small squares) under a microscope with a 10× objective lens. Only the cells on the left and above the edge of the large square are counted, and the cells on the right and below are not counted; calculate the cell density according to the formula: (sum of the number of cells in the 4 large squares / 4)×104 / mL.

[0370] Dilute the cell suspension to the cell concentration required for the experiment, inoculate it into a 96-well culture plate, 100 μL per well, set up a negative group and a blank group, and place it in an incubator after observation.

[0371] Cell dosing

[0372] (1) Preparation of drug stock solution (10000 μmol / L): Accurately weigh the compound (molecular weight is M) mg into a 1.5 mL centrifuge tube in an ultra-clean workbench, and add m / M×108 μL DMSO in a biological safety cabinet.

[0373] For example: weigh 0.0035 g of compound A with M=249, then the volume of DMSO added is 0.0035 / 249×108=1406 μL.

[0374] (2) Cell seeding plate (5000 / well): Open 96 wells in a biosafety cabinet, add 200 μL of sterile distilled water around the wells, and add 100 μL of 1×105 cells / mL cell suspension to the remaining wells to adjust the density of the cells to 5000 / well; incubate at 37°C, 5% CO2 for 24 h.

[0375] (3) Primary drug screening (10 μmol / L): Take a 1.5 mL sterile centrifuge tube, add 500 μL serum-free culture medium and 1 μL 10000 μmol / L compound stock solution to make a 20 μmol / L solution, shake and mix, and add 100 μL to each well of a 96-well plate (do not aspirate the previous 100 μL culture medium) to make the final concentration of the compound 10 μmol / L; repeat 5 replicates for each concentration; incubate at 37°C, 5% CO2 for 48 h.

[0376] MTT assay

[0377] After 48 h of drug treatment, the 96-well plate was placed in a biosafety cabinet after disinfection with 75% alcohol;

[0378] Add 20 μL of MTT solution (5 mg / mL, i.e., 0.5% MTT) to each well and continue culturing for 4 h;

[0379] Stop the culture and carefully remove the culture medium in the wells (if the cells are suspended, centrifuge at 3500rpm for 30min and then carefully remove the culture medium); add 150μL DMSO to each well and shake at low speed on a shaker for 15min to fully dissolve the crystals. Measure the absorbance of each well at OD 490nm using an enzyme-linked immunosorbent assay.

[0380] Control group setting and inhibition rate calculation

[0381] Blank group: wells without cells, used for adjusting the absorbance to zero (minus a little absorbance of the 96-well plate itself);

[0382] Negative control group (Control): wells containing cells with a drug concentration of 0. The cell viability of this group is taken as 100% in the experiment. Drug treatment group (Drug): groups treated with drugs at different concentrations

[0383] Positive control: refers to a known effective drug that is similar to the test article and is used as a control.

[0384]

[0385] Cellinhibition=1-Cellviability Formula 1: Cell viability and inhibition rate calculation formula

[0386] Table 5 Antitumor activity of compounds E1-E25

[0387]

[0388] Table 6 Antitumor activity of compounds S1-S21

[0389]

[0390]

[0391] Table 7 Antitumor activity of compounds O1-O22

[0392]

[0393] a Reference drug: 5-F: 5-fluorouracil

[0394] " / " indicates inactive

[0395] In the in vitro cell anti-tumor activity test, the broad-spectrum anti-tumor drug 5-fluorouracil was used as the positive control drug to screen the anti-tumor activity of the compounds. The target compound E25 was superior to the control at a concentration of 10 μmol / L against K562. Compound S11 had better inhibitory activity against PC-3, A549, K562, and 5637 than the positive control. Compounds O11 and O20 had excellent inhibitory activity against K562 at a concentration of 10 μmol / L. Other compounds also had moderate inhibitory activity against several tumor cells.

[0396] Pharmacological Example 2:

[0397] Antimicrobial activity testing.

[0398] The turbidity method was used to test the inhibition rate of the target compound on plant pathogens. The test objects were Xanthomonas oryzae pv.oryzae, Xoo, Xanthomonas axonopodis pv.citri, Xac, and P.syringae pv.Actinidiae, Psa. DMSO dissolved in the culture medium was used as a blank control. The rice bacterial blight pathogen (the rice bacterial blight pathogen on M210 solid culture medium) was placed in NB culture medium, and cultured in a constant temperature shaker at 28°C and 180 rpm until the logarithmic growth phase for later use; the citrus canker pathogen (on M210 solid culture medium) was placed in NB culture medium, and cultured in a constant temperature shaker at 28°C and 180 rpm until the logarithmic growth phase for later use; the kiwi fruit bacterial canker pathogen (on M210 solid culture medium) was placed in NB culture medium, and cultured in a constant temperature shaker at 28°C and 180 rpm until the logarithmic growth phase for later use.

[0399] 5 mL of toxic NB liquid culture medium with different concentrations (e.g., 100, 50 μg / mL) of the drug (compound) was added to a test tube, and 40 μL of NB liquid culture medium containing plant pathogenic bacteria was added respectively, and the mixture was shaken in a constant temperature shaker at 28-30°C and 180 rpm, and the rice bacterial blight pathogen was cultured for 36 hours, the citrus canker pathogen was cultured for 48 hours, and the kiwifruit bacterial canker pathogen was cultured for 36 hours. The OD595 value of the bacterial solution of each concentration was measured on a spectrophotometer, and the OD595 value of the toxic sterile NB liquid culture medium of the corresponding concentration was also measured.

[0400] The effective medium concentration of the target compound against plant pathogens was tested by turbidity method. The test objects were Xanthoceras oryzae (Xoo), Xanthoceras citri citri (Xac), Psoralea kiwifruit (Psa) and Rs. DMSO was dissolved in the culture medium as a blank control. Xanthoceras oryzae (Xoo) was placed in NB culture medium and cultured in a constant temperature shaker at 28℃ and 180rpm until the logarithmic growth phase; Xanthoceras citri citri (on M210 solid culture medium) was placed in NB culture medium and cultured in a constant temperature shaker at 28℃ and 180rpm until the logarithmic growth phase; Psoralea kiwifruit (on M210 solid culture medium) was placed in NB culture medium and cultured in a constant temperature shaker at 28℃ and 180rpm until the logarithmic growth phase; Psoralea kiwifruit (on M210 solid culture medium) was placed in NB culture medium and cultured in a constant temperature shaker at 28℃ and 180rpm until the logarithmic growth phase. 5 mL of NB liquid medium containing different concentrations of the compound (e.g., 100, 50, 25, 12.5, 6.25 μg / mL) was added to the test tube, and 40 μL of NB liquid medium containing plant pathogenic bacteria was added respectively. The mixture was shaken in a constant temperature shaker at 28-30°C and 180 rpm. The rice bacterial blight pathogen was cultured for 36 hours, the citrus canker pathogen was cultured for 48 hours, and the kiwi bacterial canker pathogen was cultured for 36 hours. The OD of the bacterial solution of each concentration was measured on a spectrophotometer. 595 The OD of the corresponding concentration of toxic sterile NB liquid culture medium was also measured. 595 value.

[0401] Corrected OD value = OD value of bacterial culture medium - OD value of sterile culture medium

[0402] Inhibition rate % = [(corrected control culture medium bacterial solution OD value - corrected toxic culture medium OD value) / corrected control culture medium bacterial solution OD value] × 100

[0403] The embodiments of the present invention are used to illustrate the technical solutions of the present invention, but the contents of the embodiments are not limited thereto. The experimental results of some target compounds are shown in Tables 8 and 9. Table 8 shows the antibacterial activity of the F series compounds, and Table 9 shows the antibacterial activity of the S series compounds.

[0404] Table 8 Activity of compounds F1-F23 against four plant pathogens

[0405]

[0406] “ / ” means no activity

[0407] "BT" stands for chlorothalonil

[0408] "TC" stands for Thiophanate-copper

[0409] Table 9 Activity of compounds S1-S21 against three plant pathogens

[0410]

[0411] “ / ” means no activity

[0412] "BT" stands for chlorothalonil

[0413] "TC" stands for Thiophanate-copper

[0414] In the in vitro test, the marketed drugs chlorothalonil BT and thiophanate-methyl TC were used as positive control drugs, and the activity of some compounds against rice bacterial blight pathogen, kiwi fruit canker pathogen, citrus canker pathogen and tobacco bacterial wilt pathogen was tested. Among the target compounds tested, the F series compound F16 and the S series compounds, especially S7, were superior to the control drugs BT and TC against rice bacterial blight pathogen at a concentration of 50 μg / mL, and also showed good activity against living organisms.

[0415] Parts or structures not specifically described in the present invention may adopt existing technologies or existing products and will not be described in detail here.

[0416] The above descriptions are merely embodiments of the present invention and are not intended to limit the patent scope of the present invention. Any equivalent structure or equivalent process transformation made using the contents of the present invention specification, or directly or indirectly applied in other related technical fields, are also included in the patent protection scope of the present invention.

Claims

1. A class of 3-substituted pyrazole indole biological compounds, wherein the class of 3-substituted-1-H-indole pyrazole derivative compounds has a structure as shown in the general formula (I-III): in, R1 is a single substitution or one or more substitutions of halogen, alkoxy, alkyl, trifluoromethyl, trifluoromethoxy, phenoxy or nitro; R2 is a single substitution or one or more substitutions of alkyl, halogen-substituted phenyl or pyridine or pyrimidine, alkoxy-substituted phenyl or pyridine or pyrimidine, nitro or substituted benzyl; R3 is a single substitution or one or more substitutions of halogen, alkoxy, alkyl, trifluoromethyl, trifluoromethoxy, amino or nitro; X=S / O.

2. A 3-substituted-1-H-indolepyrazole derivative compound according to claim 1, characterized in that: R1 is C1-C6 alkyl, halogen, trifluoromethyl, trifluoromethoxy, C1-C6 alkoxy, nitro, alkoxy, phenoxy; R2 is C1-C6 alkyl, halogen-substituted phenyl or pyridine or pyrimidine, trifluoromethyl-substituted phenyl or pyridine or pyrimidine, trifluoromethoxy-substituted phenyl or pyridine or pyrimidine, C1-C6 alkoxy-substituted phenyl or pyridine or pyrimidine, nitro-substituted benzyl; R3 is alkyl, halogen, trifluoromethyl, trifluoromethoxy, C1-C6 alkoxy, nitro, alkoxy.

3. A 3-substituted-1-H-indolepyrazole derivative compound according to claim 1, characterized in that: The indole 3-pyrazole ring derivative compound is selected from the following compounds:

4. A method for preparing a 3-substituted-1-H-indolepyrazole derivative compound according to any one of claims 1 to 3, characterized in that: The following steps are involved:

5. A composition, characterized in that: A compound according to any one of claims 1 to 2 or its stereoisomer, or a salt or a solvate thereof, and an agricultural adjuvant or fungicide, insecticide or herbicide.

6. Use of the compound according to any one of claims 1 to 2, or the composition according to claim 5, in the preparation of drugs for controlling agricultural pests and diseases and anti-tumor drugs.

7. The use according to claim 6, characterized in that: The agricultural pests and diseases are plant bacterial or fungal diseases.

8. The use according to claim 6, characterized in that: The agricultural pests and diseases are rice bacterial blight, citrus canker and kiwi fruit canker.

9. The use according to claim 6, characterized in that: The tumors are K562 (chronic myeloid leukemia cells), A549 (human non-small cell lung cancer cells), PC-3 (human prostate cancer cells), and 5637 (human bladder cancer cells).